---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-188075"
form_type: "8-K"
ticker: "PSTV"
cik: "0001095981"
company_name: "PLUS THERAPEUTICS, INC."
filed_at: "2025-08-26T23:59:59+00:00"
generated_at: "2026-05-17T09:53:24.849540+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Plus Therapeutics regains Nasdaq compliance on two listing rules; bid price deadline extended to Nov 12, 2025

## Summary
- Nasdaq confirmed compliance with MVLS ($35M) and equity ($2.5M) standards on Aug 22, 2025.
- Bid price rule deadline extended to Nov 12, 2025; prior Sept 8 deadline no longer applies.
- One-year monitoring for equity standard through Aug 22, 2026; breach triggers delist process without cure period.
- Company now satisfies two alternative criteria under Nasdaq Listing Rule 5550.

## SEC filing metadata
- accession: 0001193125-25-188075
- form_type: 8-K
- ticker: PSTV
- cik: 0001095981
- company_name: PLUS THERAPEUTICS, INC.
- filed_at: 2025-08-26T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.75
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1095981/000119312525188075/0001193125-25-188075-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1095981/000119312525188075/d919644d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-188075
- JSON: https://secwatch.observer/filing/0001193125-25-188075.json
- Plain text: https://secwatch.observer/filing/0001193125-25-188075.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.